ReviewInfection2021

Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature.

Simone Meini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.